The global automated cell culture systems market is poised for significant growth, with projections estimating an increase from USD 10.91 billion in 2022 to USD 20.87 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 8.4% over the forecast period.
Automated cell culture systems currently hold a 44.5% share in the global cell culture market, reflecting their growing importance in biomedical research and pharmaceutical development. The expansion of this market is being driven by several key factors, including rising investments in stem cell research, increased drug discovery efforts, and advancements in product innovation.
Key Drivers of Growth:
- Rising Stem Cell Research: The demand for automated systems is rising in response to increased research and development in stem cell therapies, a field that promises breakthroughs in treating a wide array of medical conditions.
- Drug Discovery and Development: Automated cell culture systems streamline the drug development process, enabling faster and more efficient production of cell cultures for testing new pharmaceutical products.
- Innovations and Investments: Significant investments by industry leaders are fueling the development of cutting-edge automated culture systems, which are designed to reduce human error, improve efficiency, and enhance reproducibility in cell culture workflows.
As the global healthcare landscape continues to evolve, automated cell culture systems are becoming integral to advancing life sciences research and accelerating medical breakthroughs. The growing adoption of these systems highlights their role in driving innovation across stem cell research, drug development, and other critical areas of healthcare.
Automated cell culture systems currently hold a substantial 44.5% share of the global cell culture market, reflecting their pivotal role in advancing biological research and pharmaceutical development. The expansion of this market is being driven by several key factors, including rising investment in stem cell research and development, recent drug breakthroughs, and increased funding towards the development of innovative cell culture technologies.
The surge in demand for automated systems is attributed to their ability to enhance efficiency, reproducibility, and scalability in cell culture processes. These advancements are critical for accelerating research and development efforts, particularly in the fields of drug discovery and regenerative medicine.
Besides, 3D cell cultures, which were cumbersome and costly earlier, have become feasible, owing to advent of spheroids. Also, they imitate tumors better due to hypoxic core and presence of nutrient gradient.
Researchers in the US and Germany have come up with a protocol to grow 3D cultures of generally used cancer cells to facilitate drug screenings. These factors will continue to put North America and Europe at the top pedestal in the automated cell culture systems market.
Further, the requirement of cell lines for devising vaccines against COVID-19 infection will augur well for the automated cell culture market despite the pandemic-induced economic downturn.
Automated Cell Culture Systems Market Outlook & Key Findings
- Automated cell culture systems market is expected to witness a CAGR of 8% through 2030
- Growing applications of cell lines in drug discovery to be a key growth driver
- Consumables hold more than 60% of market value owing to ever-increasing research in stem cells and oncology
- North America to capture more than 40% of market value and is expected to witness a CAGR of 6% through 2030
- Biotech companies to remain prominent end users throughout the forecast period
Key Takeaways from the Automated Cell Culture Systems Market
- Consumables are expected to reach US$ 11 Bn by 2030
- Academic institutes are expected to take greater interest in research related to cell culture over the forecast period due to increased government funding in developed countries
- North America and Europe collectively accounted for more than 60% of market share in 2019
- Infinite cell line cultures held close to 75% of market share in 2019
“Advancements in technology, coupled with large-scale applications in cell-based drug delivery and drug discovery, are projected to drive the global automated cell culture systems market” – says the FMI analyst.
A Old Full Report Analysis Click Here
Key Segments of Automated Cell Culture Systems Industry Survey
Automated Cell Culture Systems Market by Product:
- Automated Cell Culture Storage Equipment
- Automated Cell Culture Vessels
- Bioreactors
- Consumables
Automated Cell Culture Systems Market by Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
Automated Cell Culture Systems Market by Application:
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
Automated Cell Culture Systems Market by End User:
- Biotech Companies
- Research Organizations
- Academic Institutes
Automated Cell Culture Systems Market by Region:
- North America Automated Cell Culture Systems Market
- Latin America Automated Cell Culture Systems Market
- Europe Automated Cell Culture Systems Market
- East Asia Automated Cell Culture Systems Market
- South Asia & Pacific Automated Cell Culture Systems Market
- Middle East & Africa (MEA) Automated Cell Culture Systems Market
Automated Cell Culture Systems Market: Competitive Insights
The global automated cell culture systems market is set to expand its scope in the forecast period, stimulated by increasing drug discovery research and diverse applications of cell lines in research purposes. Furthermore, automated cell culture systems are used for experiments in drug discovery research and in cell banking process. In addition, cost effectiveness and rise in alternative methods for traditional cell culture production is augmenting the adoption of automated cell culture systems.
Key market players covered in the market include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Tecan Trading AG, Hamilton Medical AG., Biospherix and Promocell GmbH. Key players integrate their positions through acquisitions, mergers and new product launches.
Want more insights?
The study provides compelling insights on automated cell culture systems market on basis of product type (automated cell culture storage equipment, automated cell culture vessels, bioreactors and consumables), cell culture type (finite cell line cultures, infinite cell line cultures), application (drug development, stem cell research, regenerative medicine and cancer research) and end user (biotech companies, research organizations, academic institutes), and across seven major regions.
Author by
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
